bufotenin has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Berg, KA; Clarke, WP; Cropper, JD; Emeson, RB; Niswender, CM; Sanders-Bush, E | 1 |
2 other study(ies) available for bufotenin and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Topics: Amphetamines; Animals; Arachidonic Acid; Binding, Competitive; Bufotenin; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Ergolines; Inositol Phosphates; Lysergic Acid Diethylamide; Piperazines; Protein Isoforms; Quipazine; Radioligand Assay; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; RNA Editing; Serotonin; Serotonin Receptor Agonists; Tritium | 2001 |